title: [Which anticoagulation therapy in old atrial fibrillation patients?].
abstract: ESC recommends treating all AF patients over 75 years old with Vitamin K antagonist or new oral anticoagulation treatments because of the benefit on ischemic events. The challenge is to deal with hemorrhagic risk which should be carefully evaluated. It increases in case of renal disturbance and low weight, especially with new oral anticoagulation therapy.
authors.affiliation: Centre hospitalier d'Aix-en-Provence, service de cardiologie, 13600 Aix-en-Provence, France. jtaieb@ch-aix.fr
authors.forename: Jérôme
authors.initials: J
authors.lastname: Taieb
mesh_terms: D000368:Aged; D000465:Algorithms; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications*; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D013923:Thromboembolism / Q000209:etiology* / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants